Measuring polymyxin uptake by renal tubular cells: is BODIPY-polymyxin B an appropriate probe?
作者信息
Azad Mohammad A K, Yun Bo, Roberts Kade D, Nation Roger L, Thompson Philip E, Velkov Tony, Li Jian
机构信息
Drug Delivery, Disposition and Dynamics, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, Victoria, Australia.
Drug Delivery, Disposition and Dynamics, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, Victoria, Australia Medicinal Chemistry, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, Victoria, Australia.
出版信息
Antimicrob Agents Chemother. 2014 Oct;58(10):6337-8. doi: 10.1128/AAC.03733-14.
Abstract
摘要
相似文献
1
Measuring polymyxin uptake by renal tubular cells: is BODIPY-polymyxin B an appropriate probe?
Antimicrob Agents Chemother. 2014 Oct;58(10):6337-8. doi: 10.1128/AAC.03733-14.
2
Reply to "measuring polymyxin uptake by renal tubular cells: is BODIPY-polymyxin B an appropriate probe?".
Antimicrob Agents Chemother. 2014 Oct;58(10):6339. doi: 10.1128/AAC.03784-14.
3
Uptake of polymyxin B into renal cells.
Antimicrob Agents Chemother. 2014 Jul;58(7):4200-2. doi: 10.1128/AAC.02557-14. Epub 2014 Apr 14.
4
Mechanisms of gelofusine protection in an in vitro model of polymyxin B-associated renal injury.
Am J Physiol Renal Physiol. 2024 Jul 1;327(1):F137-F145. doi: 10.1152/ajprenal.00029.2024. Epub 2024 May 23.
5
Cellular Uptake and Localization of Polymyxins in Renal Tubular Cells Using Rationally Designed Fluorescent Probes.
Antimicrob Agents Chemother. 2015 Dec;59(12):7489-96. doi: 10.1128/AAC.01216-15. Epub 2015 Sep 21.
6
Proximal tubular epithelial cells preferentially endocytose covalently-modified albumin compared to native albumin.
Nephrology (Carlton). 2019 Jan;24(1):121-126. doi: 10.1111/nep.13211.
7
Molecular mechanisms of receptor-mediated endocytosis in the renal proximal tubular epithelium.
J Biomed Biotechnol. 2010;2010:403272. doi: 10.1155/2010/403272.
8
Gadolinium modulates gentamicin uptake via an endocytosis-independent pathway in HK-2 human renal proximal tubular cell line.
Eur J Pharmacol. 2012 Jun 5;684(1-3):146-53. doi: 10.1016/j.ejphar.2012.03.030. Epub 2012 Mar 29.
9
Deletion of insulin receptor in the proximal tubule and fasting augment albumin excretion.
J Cell Biochem. 2019 Jun;120(6):10688-10696. doi: 10.1002/jcb.28359. Epub 2019 Jan 15.
10
Novel polymyxin derivatives are less cytotoxic than polymyxin B to renal proximal tubular cells.
Peptides. 2012 Jun;35(2):248-52. doi: 10.1016/j.peptides.2012.03.033. Epub 2012 Apr 6.
引用本文的文献
1
Rescuing the Last-Line Polymyxins: Achievements and Challenges.
Pharmacol Rev. 2021 Apr;73(2):679-728. doi: 10.1124/pharmrev.120.000020.
2
Investigating the Interaction of Octapeptin A3 with Model Bacterial Membranes.
ACS Infect Dis. 2017 Aug 11;3(8):606-619. doi: 10.1021/acsinfecdis.7b00065. Epub 2017 Jul 11.
3
Polymyxins Facilitate Entry into Mammalian Cells.
Chem Sci. 2016 Aug 1;7(8):5059-5068. doi: 10.1039/C6SC00488A. Epub 2016 Apr 25.
4
Quantitation of Polymyxin-Lipopolysaccharide Interactions Using an Image-Based Fluorescent Probe.
J Pharm Sci. 2016 Feb;105(2):1006-1010. doi: 10.1016/j.xphs.2015.10.028. Epub 2016 Jan 9.
5
Human oligopeptide transporter 2 (PEPT2) mediates cellular uptake of polymyxins.
J Antimicrob Chemother. 2016 Feb;71(2):403-12. doi: 10.1093/jac/dkv340. Epub 2015 Oct 22.
6
Cellular Uptake and Localization of Polymyxins in Renal Tubular Cells Using Rationally Designed Fluorescent Probes.
Antimicrob Agents Chemother. 2015 Dec;59(12):7489-96. doi: 10.1128/AAC.01216-15. Epub 2015 Sep 21.
7
Reply to "measuring polymyxin uptake by renal tubular cells: is BODIPY-polymyxin B an appropriate probe?".
Antimicrob Agents Chemother. 2014 Oct;58(10):6339. doi: 10.1128/AAC.03784-14.
本文引用的文献
1
Uptake of polymyxin B into renal cells.
Antimicrob Agents Chemother. 2014 Jul;58(7):4200-2. doi: 10.1128/AAC.02557-14. Epub 2014 Apr 14.
2
Probing the penetration of antimicrobial polymyxin lipopeptides into gram-negative bacteria.
Bioconjug Chem. 2014 Apr 16;25(4):750-60. doi: 10.1021/bc500094d. Epub 2014 Mar 27.
3
Higher incidence of acute kidney injury with intravenous colistimethate sodium compared with polymyxin B in critically ill patients at a tertiary care medical center.
Clin Infect Dis. 2013 Nov;57(9):1300-3. doi: 10.1093/cid/cit453. Epub 2013 Jul 9.
4
Pharmacology of polymyxins: new insights into an 'old' class of antibiotics.
Future Microbiol. 2013 Jun;8(6):711-24. doi: 10.2217/fmb.13.39.
5
Population pharmacokinetics of intravenous polymyxin B in critically ill patients: implications for selection of dosage regimens.
Clin Infect Dis. 2013 Aug;57(4):524-31. doi: 10.1093/cid/cit334. Epub 2013 May 22.
6
Incidence and predictors of acute kidney injury associated with intravenous polymyxin B therapy.
J Infect. 2012 Jul;65(1):80-7. doi: 10.1016/j.jinf.2012.01.015. Epub 2012 Feb 2.
7
Design, synthesis, and evaluation of a new fluorescent probe for measuring polymyxin-lipopolysaccharide binding interactions.
Anal Biochem. 2011 Feb 15;409(2):273-83. doi: 10.1016/j.ab.2010.10.033. Epub 2010 Nov 2.
8
Structure--activity relationships of polymyxin antibiotics.
J Med Chem. 2010 Mar 11;53(5):1898-916. doi: 10.1021/jm900999h.
9
Nephrotoxicity associated with intravenous colistin (colistimethate sodium) treatment at a tertiary care medical center.
Clin Infect Dis. 2009 Jun 15;48(12):1724-8. doi: 10.1086/599225.
10
The search for molecular determinants of LPS inhibition by proteins and peptides.
Curr Top Med Chem. 2004;4(11):1185-201. doi: 10.2174/1568026043388105.
Zotero 插件